Tag: NAFDAC

NAFDAC raises alarm over “manpower” being used by men

The National Agency for Food and Drugs Administration and Control (NAFDAC) has raised an alarm over the use of PrimeZen Black 6000mg, a male performance enhancement capsule known in local parlance as “manpower”.

TheNewsGuru.com (TNG) reports NAFDAC as saying the male performance enhancement capsule contains undeclared ingredients they were made of and therefore, has been recalled, following an analysis by the Food and Drug Agency (FDA) of the United States of America (USA).

NAFDAC in a public alert with No. 015/2023, issued on Sunday in Abuja by its Director-General, Prof Mojisola Adeyeye, therefore, warned users/consumers against the use of the male performance enhancement capsule recalled from the market.

Adeyeye said that Volt Candy is voluntarily recalling the one lot of PrimeZen Black 6000mg capsule alongside its 2000mg, due to undeclared ingredients they were made of by their manufacturer in America.

“The recall followed the analysis of Food and Drug Agency (FDA) of the United States of America, an FDA, which found the PrimeZen capsules to contain undeclared tadalafil and sildenafil.

“Sildenafil and tadalafil are phosphodiesterase (PDE-5) inhibitors found in FDA-approved products for the treatment of male erectile dysfunction.

“The presence of sildenafil and tadalafil in PrimeZen Black 6000mg capsules renders them unapproved drugs for which safety and efficacy have not been established and, therefore, subject to recall.

“Risk Statement, PrimeZen Black 6000 capsules containing sildenafil and tadalafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life-threatening.

“People with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

“Among the adult male population who are most likely to use these products, adult males who use nitrates for cardiac conditions are most at risk from these products,” she said.

According to her, “The product details are as follows; PrimeZEN Black 6000 male enhancement capsules, manufactured by Volt Candy, 324 S. Diamond Bar Blvd #212, USA.”

The NAFDAC boss said that the lot Number: NPINPB 1003, UPC code: 728175521891, expiration date is Aug. 16, 2025 for PrimeZen Black 6000mg being marketed online as a dietary supplement for male enhancement and is packaged in a blister card with one capsule.

Adeyeye added that the product can be identified by the card color in black with the name on it PrimeZen Black 6000.

She said, “NAFDAC hereby implores members of the public in possession of the above product to stop the sale or use, as well as handover the product to the nearest agency office.”

The DG appealed to those who have the falsified product, to “please DO NOT use it.”

“If you, or someone you know, have used the product, or suffered any adverse reaction after use, please seek immediate medical advice,” she advised.

She also advised healthcare professionals and consumers to report any suspicion of adverse drug reaction, substandard and falsified medicines to the nearest NAFDAC office.

Adeyeye said that the public was also advised to report any adverse reactions to the product to NAFDAC on 0800-162-3322 or via email: alert@nafdac.gov.ng”.

The DG also encouraged healthcare professionals and patients to report adverse events or side effects related to the use of medicinal products through the use of the E-reporting platforms available on the NAFDAC website “http://www.nafdac.gov.ng/”.

May 14, 2023
NAFDAC to start testing Indomie noodles in Nigeria on Tuesday

The National Agency for Food and Drug Administration and Control, NAFDAC has concluded plans to start testing Indomie noodles, including the seasoning from the production companies on Tuesday (today).

NAFDAC also said the importation of Indomie noodles into Nigeria had been banned for many years and the products were on the prohibition list.

This is following the detection of a compound called ethylene oxide, a potentially cancer-causing substance in Indomie’s “special chicken” flavour noodles by health officials in Malaysia and Taiwan.

Both Malaysia and Taiwan have recalled the product.

The makers of Indomie noodles, Indofod, defended the safety of its products, saying all instant noodles produced by the ICBP in Indonesia were processed in compliance with the food safety standards from the Codex Standard for Instant Noodles and standards set by the Indonesian National Agency for Drug and Food Control.

“ICBP has exported instant noodles to various countries around the world for more than 30 years.

The company continuously ensures that all of its products are in compliance with the applicable food safety regulations and guidelines in Indonesia as well as other countries where the ICBP’s instant noodles are marketed,” a press statement by Indofood read in part.

According to the National Cancer Institute, ethylene oxide is a flammable colourless gas with a sweet odour at room temperature.

“It is used primarily to produce other chemicals, including antifreeze. In smaller amounts, ethylene oxide is used as a pesticide and a sterilising agent. The ability of ethylene oxide to damage DNA makes it an effective sterilising agent but also accounts for its cancer-causing activity,” the institute said.

Indomie is a brand of instant noodles produced by the Indonesian company, Indofood and Nigeria is one of the biggest consumers of instant noodles.

Indomie is also exported to more than 90 countries around the world.

Meanwhile, the Director-General of NAFDAC, Prof Mojisola Adeyeye told The Punch on Monday that the agency has started investigating and responding immediately to the news of the recalled Indomie noodles by Taiwan and Malaysia authorities.

Prof Adeyeye said, “Tomorrow, (Tuesday) May 2, 2023, NAFDAC’s Food Safety and Applied Nutrition Directorate will randomly sample Indomie noodles (including the seasoning) from the production facilities while Post Marketing Surveillance Directorate samples from the markets. The compound of interest is ethylene oxide, so the Director, Food Lab Services Directorate has been engaged. He is working on the methodology for the analysis.

“It should be noted that Indomie noodles have been banned from being imported into the country for many years. It is one of the foods on the government prohibition list. It is not allowed in Nigeria, and therefore not registered by NAFDAC.

“What we are doing is an extra caution to ensure that the product is not smuggled in and if so, our post-marketing surveillance would detect it. We also want to be sure that the spices used for the Indomie and other noodles in Nigeria are tested. That is what NAFDAC Food Safety and Applied Nutrition and Post Marketing Surveillance are doing this week at the production facilities and in the market respectively.”

Adeyeye added that the public will be duly updated with the outcomes of the investigation.

May 1, 2023
Breaking! NAFDAC bans importation of Indomie noodles

…over its alleged link to cancerous elements

The National Agency for Food and Drug Administration and Control (NAFDAC) has said that importation of Indomie noodles to Nigeria has been banned following allegations of a cancer-causing chemical found in the noodles and non-registration of the agency.

TheNewsGuru.com, (TNG) recalls health officials in Malaysia and Taiwan recently detected ethylene oxide, a compound in Indomie’s “special chicken” flavour noodles.

Ethylene oxide is a colourless, odourless gas that is used to sterilise medical devices and spices and is said to be a cancer-causing chemical.

The ministry of health in Malaysia noted that it examined 36 samples of instant noodles from different brands since 2022 and found that 11 samples contained ethylene oxide.

Both countries have since recalled the product.

Speaking about the development, Mojisola Adeyeye, NAFDAC director-general, said the agency would begin random sample tests of the noodles and other brands from May 2.

Speaking with Newsmen on Monday, Adeyeye said the NAFDAC started investigating once it got wind of the recall of the products by Taiwan and Malaysia authorities.

“Tomorrow, May 2, 2023, NAFDAC’s food safety and applied nutrition directorate will randomly sample Indomie noodles (including the seasoning) from the production facilities while post marketing surveillance directorate (will) samples from the markets,” she said.

The compound of interest is ethylene oxide, so the director, food lab services directorate has been engaged. He is working on the methodology for the analysis.”

The DG said the product is on the prohibition list of the federal government, adding that it is not registered by the agency and had been banned from importation to Nigeria years ago.

May 1, 2023
NAFDAC alerts Nigerians about killer cough syrup

The National Agency for Food and Drug Administration and Control (NAFDAC) on Wednesday in Abuja alerted Nigerians about a killer cough syrup, NATURCOLD.

Its Director-General, Prof. Mojisola Adeyeye, stated that the cough syrup already caused the death of six children in Cameroon.

Adeyeye stated that the cough syrup was not in NAFDAC’s database, and advised importers, distributors, retailers, and consumers to exercise caution and vigilance within the supply chain.

She called on importers, distributors, retailers, and consumers to avoid the importation, distribution, sale and consumption of the substandard syrup.

“All medical products must be obtained from authorised/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.

“NAFDAC implores members of the public to desist from buying medicinal products from unauthorised sources such as roadside vendors and street hawkers,’’ she stated.

Adeyeye added that fake drugs were mostly smuggled into the country from neighbouring countries and distributed through inappropriate channels.

She enjoined anyone in possession of NATURCOLD to discontinue its sale or use and submit stock to the nearest NAFDAC office.

“If you know anyone who have used these product, or suffered any adverse reaction after use, such person is advised to seek immediate medical advice from a qualified healthcare professional,’’ she stressed.

Adeyeye also advised healthcare professionals and consumers to report any suspicion of sale and use of substandard and falsified medicines to the nearest NAFDAC office.

She explained that Cameroon’s Ministry of Public Health already issued an alert regarding the suspected substandard cough syrup.

She added that the death of the six victims of the cough syrup was recorded at a health facility in the district of Fundong, North-West region of Cameroon.

She quoted the delegate for Public Health in the region as saying that children who took the syrup showed a decrease in kidney function.

The syrup was not authorised for marketing in Cameroon and was bought from unauthorised sources, the delegate also said.

Adeyeye encouraged healthcare professionals and patients to report adverse side effects of medicinal products to the nearest NAFDAC office, or through e-reporting.

NAFDAC’s e-reporting platforms include: www.nafdac.gov.ng and pharmacovigilance@nafdac.gov.ng.

April 26, 2023
BREAKING: Vaccine approved for Malaria in Nigeria

The National Agency for Food and Drug Administration and Control (NAFDAC) said it has granted approval to Serum Institute Pvt. Ltd. (SIIPL) R21 malaria vaccine for the treatment of malaria in Nigeria.

TheNewsGuru.com (TNG) reports the Director-General, Prof. Mojisola Adeyeye, said this at a news conference on Monday in Abuja.

She said that the granting of registration/approval was in line with the agency’s mandate as stipulated by its enabling law — NAFDAC Act CapN1, Law of the Federation of Nigeria (LFN) 2004.

Adeyeye said that it became necessary to grant approval for the vaccine following the 2021 World Malaria Report that Nigeria had the highest number of global malaria cases of 27 per cent.

She said the highest number of deaths stood at 32 per cent of global malaria deaths in 2020, adding that Nigeria accounted for an estimated 55.2 per cent of malaria cases in West Africa in 2020.

“Malaria is one of the most important public health concerns in the world, the latest World Health Organisation (WHO) Malaria Report shows there were 247 million cases of malaria in 2021 compared to 245 million cases in 2020.’’

She explained that the estimated number of malaria deaths stood at 619000 in 2021 compared to 625000 in 2020.

“Over the two peak years of the pandemic (2020–2021), COVID-related disruptions led to about 13 million more malaria cases and 63000 more malaria deaths.

“The WHO African Region continues to carry a disproportionately high share of the global malaria burden. In 2021 the region was home to about 95 per cent of all malaria cases and 96 per cent of deaths.

“Children under five years of age accounted for about 80 per cent of all malaria deaths in the region. Four African countries accounted for just over half of all malaria deaths worldwide, with Nigeria; 31.3 per cent, the Democratic Republic of the Congo; 12.6 per cent, United Republic of Tanzania; 4.1 per cent and Niger; 3.9 per cent respectively.

“Malaria is transmitted throughout Nigeria, with 97 per cent of the population at risk. The duration of the transmission season ranges from year-round transmission in the south to three months or less in the north,’’ she stressed.

She said that the Marketing Authorisation Holder’s (MAHs) for the vaccine is Fidson Healthcare Ltd, which had the agency’s Drug and Related Products Registration Regulation 2021.

According to Adeyeye, the R21 malaria vaccine is an adjuvanted protein vaccine presented as a sterile solution.

She explained that “a dose, which is 0.5ml, is composed of R21 Malaria antigen 5µg and Matrix-M1 50µg as an adjuvant filled in a vial as ready to use liquid formulation for intramuscular injection.’’

She said that the vaccine is indicated for prevention of clinical malaria in children from five months to 36 months of age, adding that the storage temperature of the vaccine is 2-8 °C.

The NAFDAC boss said the agency had several pathways for registration of vaccines, in line with the agency’s guideline for registration of Imported Drugs, Vaccines and IVDs under Collaborative Registration Procedure.

Adeyeye said the agency received the dossier of the R21 Malaria manufactured by SIIPL and subjected it to independent review at two different levels.

She added that as a matured regulatory agency, it is expected as part of global benchmarking that external advisory committee was put in place to give advise upon invitation on certain functions of the agency.

She said that as a new biological molecule being given consideration for full registration, the independent review by an external body became imperative to further safeguard public health.

The external advisory body known as NAFDAC’s Vaccine Advisory Committee (NEVAC) is made up of four highly recognised, well-published experts from Nigeria’s tertiary institutions, she said.

She listed the institutions where the advisory body members were selected as Nnamdi Azikwe University, Awka, Anambra State; University of Lagos, Lagos State, University of Ibadan, Oyo State and Usman Dan Fodio University, Sokoto, Sokoto State.

Adeyeye said that the agency also had in-house Vaccine Review Committee (NEVAC) extracted from different directorates of NAFDAC to oversee, evaluate, as well as carry out clinical trials on vaccine before approval was made.

She said that the dossier was reviewed using WHO standard across relevant domains, in addition to the European Medicines Agency guidelines (where appropriate), scientific rigor on the vaccine.

According to her, the review of NAFDAC’s committee has always been guided by the same international standards and best practices with the same modality of independent review by members.

“This is followed by long hours of plenary where rigorous assessment of each review took place.’’

She said that the committee also independently scored the assessment as satisfactory, which was then forwarded to the director-general and that upon submission of the reviews of both committees, the NAFDAC boss called for a joint review session on April 14.

Adeyeye said that the joint review process provided the opportunity to harmonise the assessments, the outcomes of the reviews were discussed, and the recommendations and queries/clarifications were consolidated to be referred to the manufacturers.

She said that the R21 Malaria Vaccine dossier complied substantially with best international standards with which the dossier was benched-marked.

She added that the Joint Review Committee concluded that the data on the R21 malaria vaccine were robust and met criteria for efficacy, safety and quality.

April 17, 2023
NAFDAC bursts sex enhancement drugs store in Onitsha

The National Agency for Food and Drug Administration (NAFDAC) on Friday bursted a store at the Bridge Head Market, Onitsha, which specialises in the sale of expired sex enhancement drugs.

NAFDAC Chief Laboratory Technologist, Mr Usman Amen, who led the Investigation and Enforcement Directorate team from Lagos disclosed that the store was notorious for dealing in unregistered and expired drugs.

According to him, the operation was carried out, following a tip off on the nefarious activities going on in the market.

The store is situated at the Progressive Science and Allied Dealers Lane in the market.

Amen said the drugs included delay viagra, afrofranil, breast enhancement, ass enhancement, rocket in pocket men gel and tramadol, among others.

He said: “We came from Lagos on a tip off, before we arrived here, the owner of these sex enhancement drugs abandoned his store and ran away.

“In view of this, we had to break the store and on entering inside, we saw some expired drugs, like tramadol, breast enhancer and all kinds of sexual drug enhancers.

“We ensured that we evaluated the drugs and sealed up the store. The owner will have to come to our office in Lagos for interrogation.

“We also sealed the store in Ogbo-Ogwu Bridge Head Market because a particular drug we were informed about was not found but the invoice indicated when the drug was last sold.

“The second store was sealed because their were some drugs that are not allowed to be sold in the market, we evaluated them and sealed the store,” Amen said.

He called on the public to be vigilant, saying that the drugs being produced and sold in the market were not worth consuming.

The leader of the lane in the market, Mr George Opara, described the activities of the dealer as “embarrassing and disturbing”.

Opara said that the market was known for dealing in genuine drugs and other goods.

He said that punitive actions would be meted to the runaway shop owner for engaging in such illegal business and bringing shame to the lane.

March 31, 2023
NAFDAC moves to intensify war against sub-standard, falsified medicines

The National Agency for Food and Drug Administration and Control (NAFDAC) will intensify the fight against substandard and falsified medicines in the country with the implementation of a pharmaceutical traceability strategy to safeguard the health of the Nigerian populace.

The Director-General, Mojisola Adeyeye, stated this at at a workshop in Portharcourt, organised by the agency while finalising the draft traceability of pharmaceutical products regulations.

This is contaed in a statement signed by the NAFDAC spokesperson, Mr Olusayo Akintola in Abuja.
Adeyeye said:”the task of safeguarding the health of the nation is daunting in the face of the chaotic drug distribution system currently existing in Nigeria”.

She said that the falsification and diversion of health commodities caused serious health and economic consequences.

“The consequences vis-à-vis the mandate of the agency to regulate and control among other things, the distribution of drugs and other regulated products is sufficient motivation for the implementation of pharmaceutical traceability,” she said.

The director-general said there is need to complement the fight against the menace of substandard and falsified medicines and improve the regulatory control of the medicines supply chain in Nigeria.

She said that NAFDAC was committed to the full implementation of pharmaceutical traceability in Nigeria as part of regulatory strengthening and underscoring its mandate.

Adeyeye also said that NAFDAC has developed a five-Year traceability implementation plan in line with the objectives of the Nigeria pharmaceutical traceability strategy.

She said the idea is aimed at achieving supply chain visibility and strengthening interventions against substandard and falsified medicines by the end of her second term.

”Gazetting and dissemination of the traceability of pharmaceutical products and regulations is essential for the adoption and enforcement of the provisions of the Nigeria pharmaceutical traceability strategy.

”Also, regulation, accompanied by guidelines and compliance requirements will provide a legal framework to support advocacy for all stakeholders to implement traceability in distribution of pharmaceuticals or supply chain.

”The participation of relevant stakeholders during the drafting of the traceability regulation is important to ensure there is understanding among stakeholders,” she said.

She said that a major achievement in the direction of reducing the incidence of substandard and falsified medicines in the country was the hosting of the second Africa GSI traceability conference on healthcare in Lagos in Sept. 2019.

The conference, she said, attracted medicines regulatory agencies from about twenty-five countries in Africa, as well as other stakeholder partners from the Americas and Europe.

“The agency is already on a five-year roadmap to establishing a culture of track and trace with regards to pharmaceutical products,” she said.

Adeyeye said that medicines and medical devices can be monitored throughout the supply chain from manufacturing to the end user, the patient, adding that the agency has developed a roadmap to this effect.

She stated that the roadmap has been approved by the Minister of Health, adding that, the traceability strategy document was the outcome of the year’ (1919/2020) work by NAFDAC.

She said that the traceability document work was done in collaboration with the Ministry of Health, USAID and GS1 Technologies.

Adeyeye said that NAFDAC traceability office is being supported by international partners such as USAID, World Bank, World Health Organisation; Bill and Melinda Gates Foundation, and Global Fund.

Describing the gains of implementing pharmaceutical traceability as enormous, Adeyeye said traceability would provide visibility of medicines from plant to patient to promote trust in the pharmaceutical sector and healthcare system.

January 30, 2023
NAFDAC destroys tramadol, unregistered pharmaceuticals worth N95bn

The National Agency for Food and Drug Administration and Control, NAFDAC, has destroyed tramadol and unregistered pharmaceuticals worth N95bn.

Disclosing this at a press briefing on Monday, NAFDAC Director General, Prof Mojisola Adeyeye, said the destruction was done in December 2022 after four and half years of monitoring with the help of the government of Benin Republic.

The products found in five containers were tramadol 200mg and higher-strength, diclofenac tablets.

TheNewsGuru.com (TNG) reports that the products were destroyed in Cotonou.

Adeyeye said, “Following an intelligence report from the Presidency, the Director-General of NAFDAC in August 2018 directed the Director of Ports Inspection Directorate, Prof Samson Adebayo on the intention of some unscrupulous importers to ship 31 containers of unregistered pharmaceutical products including tramadol 200mg and above from India. The containers were labeled building materials for a bonded terminal.

“The Director, Ports Inspection Directorate, working with his Intelligence & Monitoring Unit commenced the surveillance and monitoring of the reported containers from the ports of loading to the successive ports where they were transloaded along the sea routes.

“The first approach was to collaborate with the Nigeria Customs Service. Eventually, twenty-one of the containers were discharged at the Apapa port in Lagos, Nigeria as manifested. One container couldn’t be tracked because of a missing container number. Out of the 21 containers, only two had building materials.

“However, as the importers of the containers became aware that NAFDAC was tracking and monitoring the containers on arrival at the Apapa port and intercepting them, they decided to change their strategy by diverting the remaining away from the Nigerian port. Four containers never got to Nigeria but were discharged at transshipment in Malaysia.”

According to the NAFDAC boss, one container was transferred to the Cotonou port in the Republic of Benin while the remaining four were initially diverted to the Tema Port in Ghana but later diverted to Cotonou having met resistance from Ghana Food and Drug Agency that NAFDAC already contacted for collaboration to stop the four containers.

She noted that the agency liaised with the former Ambassador of Nigeria to the Republic of Benin, Kayode Oguntuase, to ensure that the port authority in the Republic of Benin affected the seizure of the five containers.

“His successor, Olukayode Aluko never relented in his effort at ensuring that all these five containers are released to NAFDAC for destruction. Meanwhile, for the other 24 containers, some entities took the case to court in Benin that the containers should be brought back to Nigeria.

“This took about one year plus but Ambassador Aluko stayed on the case until the court made the judgment that the containers can be destroyed in Benin. Alas, the government of the Republic of Benin eventually agreed to engage with the Nigerian counterparts to carry out the destruction of these containers in Cotonou.

“A team of NAFDAC officers, including Investigation & Enforcement Directorate officers, led by the Director of Ports Inspection Directorate, Prof Adebayo, traveled to Cotonou where the destruction exercise of the five containers took place on December 21st and 22nd, 2022.

“This international landmark achievement, which had never been recorded in the history of the two countries and NAFDAC, did not come without the unflinching efforts of the staff of the Ports Inspection Directorate in Apapa and Seme Border,” she added.

January 23, 2023
NAFDAC alerts Nigerians on use of weight loss pill

The National Agency for Food and Drugs Administration and Control (NAFDAC) has cautioned Nigerians against the use of the drug — Weight Rapid Loss Capsule.

The caution is contained in an alert with No. 049/2022, signed by NAFDAC’s Director-General, Prof. Mojisola Adeyeye, issued on Sunday in Abuja.

Adeyeye stated that the drug has been found to have potential to cause cancer.

The NAFDAC boss added that result of laboratory analysis showed that the drug, manufactured by Ingi Oman, contain banned substance “phenolphthalein”, which the U.S. Food and Drug Administration recognised as unsafe.

She added that the capsule, being marketed as “the most effective weight loss supplement” and sold through social media platforms like Instagram, also contain microbial growth above permissible limits.

She stated that “phenolphthalein has been found to be toxic to genes, as it can cause damage or mutations in the DNA. Studies have also shown its potential carcinogenic risks.

“NAFDAC implores consumers to stop the purchase and use of the product.

“Members of the public in possession of the product should discontinue use or sale, and submit stock to the nearest NAFDAC office.”

Adeyeye encouraged healthcare professionals and consumers to report any adverse effect experienced with the use of the product to the nearest NAFDAC office.

Consumers are also advised to report adverse effect via pharmacovigilance@nafdac.gov.ng or E-reporting platforms available at www.nafdac.gov.ng.

The director-general urged the public to also report any incident concerning the use of the drug via the Med-safety application, which can be downloaded on android and IOS stores.

January 23, 2023
NAFDAC alerts public against use of weight loss pill

The National Agency for Food and Drugs Administration and Control (NAFDAC) has cautioned Nigerians against the use of the drug — Weight Rapid Loss Capsule.

The caution is contained in an alert with No. 049/2022, signed by NAFDAC’s Director-General, Prof. Mojisola Adeyeye issued on Sunday in Abuja.

Adeyeye stated that the drug has been found to have potential to cause cancer.

The NAFDAC boss added that result of laboratory analysis showed that the drug, manufactured by Ingi Oman, contain banned substance “phenolphthalein”, which the U.S. Food and Drug Administration recognised as unsafe.

She added that the capsule, being marketed as “the most effective weight loss supplement” and sold through social media platforms like Instagram, also contain microbial growth above permissible limits.

She stated that “phenolphthalein has been found to be toxic to genes, as it can cause damage or mutations in the DNA. Studies have also shown its potential carcinogenic risks.

“NAFDAC implores consumers to stop the purchase and use of the product.

“Members of the public in possession of the product should discontinue use or sale, and submit stock to the nearest NAFDAC office.”

Adeyeye encouraged healthcare professionals and consumers to report any adverse effect experienced with the use of the product to the nearest NAFDAC office.

Consumers are also advised to report adverse effect via pharmacovigilance@nafdac.gov.ng or E-reporting platforms available at www.nafdac.gov.ng.

The director-general urged the public to also report any incident concerning the use of the drug via the Med-safety application, which can be downloaded on android and iOS stores.

January 22, 2023